Evidence map›Paper›PMID 29094001›Full record

ArticleGMS hygiene and infection control2017

In vitro synergy of antibiotic combinations against planktonic and biofilm Pseudomonas aeruginosa.

Hossein Ghorbani, Mohammad Yousef Memar, Fatemeh Yeganeh Sefidan, Mina Yekani, Reza Ghotaslou

Open access · greenAbstract read
In one paragraph

Article in GMS hygiene and infection control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Enhanced Biofilm Disruption in Methicillin-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Bile effects on theHeliyon · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Treatment ofFrontiers in microbiology · 2022
    Review
  15. Article
  16. Iranian journal of pharmaceutical research : IJPR · 2021
    Article
  17. Article
  18. Article
  19. Resistance mechanisms and therapeutic strategies forTherapeutic advances in infectious disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hossein GhorbaniInfectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammad Yousef MemarDepartment of Microbiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Fatemeh Yeganeh SefidanDepartment of Microbiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Mina YekaniDepartment of Microbiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Reza GhotaslouDepartment of Microbiology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiofilmcombination therapyPseudomonas aeruginosasynergetic effects

Identifiers

PMID29094001
PMCPMC5647455
OpenAlexW2940638626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.